DNA co-methylation analysis of lincRNAs across nine cancer types reveals novel potential epigenetic biomarkers in cancer

Yunzhen Wei, Siyao Dong, Yanjiao Zhu, Yichuan Zhao, Cheng Wu, Yinling Zhu, Kun Li, Yan XuEpigenomics 2019 · DOI

Abstract

<b>Aim:</b> The potential functions and prognostic value of lincRNAs with co-methylation events are explored in 9 cancer types. <b>Materials & methods:</b> Here, we evaluated the co-methylation events in promoter and gene-body regions between two lincRNAs across 9 cancer types by constructing a systematic biological framework. <b>Results:</b> The co-methylation events in both promoter and gene-body regions tended to be highly cancer specific. Patient samples could be separated by tumor and normal types according to the eigengenes of universal co-methylation clusters. Functional enrichment results revealed the lincRNAs that brought promoter and gene-body co-methylation events that affected cancer progress through participating in different pathways and could serve as potential prognostic biomarkers. <b>Conclusion:</b> The study provides new insight into the epigenetic regulation in cancer and leads to a potential new direction for epigenetic biomarker discovery.
BibTeX
@inproceedings{wei2019dna,
  author = {Yunzhen Wei and Siyao Dong and Yanjiao Zhu and Yichuan Zhao and Cheng Wu and Yinling Zhu and Kun Li and Yan Xu},
  title = {{DNA co-methylation analysis of lincRNAs across nine cancer types reveals novel potential epigenetic biomarkers in cancer}},
  booktitle = {Epigenomics},
  year = {2019},
  doi = {10.2217/epi-2018-0138},
}

Loading related content...

Figure